Court Triples Damages Stratagene Must Pay Invitrogen for Willfully Infringing IP; Tab Now $16.2M

Nov 01, 2006

NEW YORK (GenomeWeb News) — A US court has awarded Invitrogen $16.2 million in damages in a patent-infringement case against Stratagene, tripling an earlier jury award, Stratagene disclosed today.

Stratagene said it would appeal the award and challenge the validity of Invitrogen’s patent that is at the center of the suit.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Standards Needed

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

Faster Profiles

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

Conflict Search

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

This Week in Science

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.

Main menu